Mousse Partners appeared to be the VC, which was created in 1994. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The usual things for fund are deals in the range of 10 - 50 millions dollars. This Mousse Partners works on 8 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Mousse Partners is 100-500 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2018. The real fund results show that this VC is 1 percentage points more often commits exit comparing to other companies.
We can highlight the next thriving fund investment areas, such as Cosmetics, E-Commerce. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Memebox, Epirus Biopharmaceuticals, Paddle8
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Mousse Partners, startups are often financed by Founder Collective, Stage One Capital, Entru00e9e Capital. The meaningful sponsors for the fund in investment in the same round are Upfront Ventures, Founder Collective, Accel. In the next rounds fund is usually obtained by Accel, Upfront Ventures, Two Sigma Ventures.
The current fund was established by Charles Heilbronn. We also calculated 7 valuable employees in our database.
|AB Accelerator||Amman, Amman, Jordan|
|Adidas||Bayern, Germany, Herzogenaurach|
|Ayce Capital Partners||Barcelona, Catalonia, Spain|
|Bitrise Capital||Central, Central Region, Singapore|
|Building Insurance Bern||-|
|Canadian Business Growth Fund||Canada, Ontario, Toronto|
|Colchis Capital Management||California, San Francisco, United States|
|Elderstreet Investments||England, London, United Kingdom|
|Forecast Communications||Japan, Tokyo|
|Luge Capital||Canada, Montréal, Quebec|
|Manchester Venture Partners||England, Manchester, United Kingdom|
|Pylon Capital||California, Santa Barbara, United States|
|Shigin Economic Research Institute||-|
|Srijan Capital||Bangalore, India, Karnataka|
|Stadtwerk Winterthur||Switzerland, Winterthur, Zurich|
|Thornton Capital||Kentucky, Louisville, United States|
|TripleTree||Minneapolis, Minnesota, United States|
Evolved By Nature
|$120M||28 Jun 2022||Massachusetts, United States|
|$50M||29 Mar 2022||San Francisco, California, United States|
Evolved By Nature
|$70M||24 Dec 2021||Massachusetts, United States|
|$35M||28 Oct 2021||New York, United States|
|$140M||02 Jun 2021||New York, New York, United States|
|$800M||28 Apr 2021||Amsterdam, North Holland, Netherlands|
|$190M||27 Apr 2021||Rockville, Maryland, United States|
|$200M||08 Oct 2020||Amsterdam, North Holland, Netherlands|
|$110M||17 Sep 2020||San Francisco, California, United States|
– Thirty Madison, a New York-based healthcare company that focuses on people with chronic conditions, raised $140M in Series C funding.
– The round was led by new investor HealthQuest Capital with participation from Mousse Partners and Bracket Capital and existing investors Polaris Partners, Johnson & Johnson Innovation – JJDC, Inc., Northzone, Greycroft, and others.
– The company intends to use the funds to expand access to its care model for people who suffer from chronic conditions and enhance the capabilities of its proprietary platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.